DA Davidson Initiates Coverage On U.S. Bancorp with Neutral Rating, Announces Price Target of $47
DA Davidson analyst Peter Winter initiates coverage on U.S. Bancorp (NYSE:USB) with a Neutral rating and announces Price Target of $47.
Maxim Group Initiates Coverage On Atlis Motor Vehicles with Buy Rating, Announces Price Target of $15
Maxim Group analyst Tate Sullivan initiates coverage on Atlis Motor Vehicles (NASDAQ:AMV) with a Buy rating and announces Price Target of $15.
EF Hutton Assumes Superior Drilling Prods at Buy, Announces Price Target of $2
EF Hutton analyst Ignacio Bernaldez assumes Superior Drilling Prods (AMEX:SDPI) with a Buy rating and announces Price Target of $2.
EF Hutton Initiates Coverage On Alpine Income Prop Trust with Buy Rating, Announces Price Target of $22
EF Hutton analyst Gaurav Mehta initiates coverage on Alpine Income Prop Trust (NYSE:PINE) with a Buy rating and announces Price Target of $22.
Barclays Initiates Coverage On InMode with Overweight Rating, Announces Price Target of $44
Barclays analyst Matt Miksic initiates coverage on InMode (NASDAQ:INMD) with a Overweight rating and announces Price Target of $44.
Evercore ISI Group Initiates Coverage On BJ’s Wholesale Club with In-Line Rating, Announces Price Target of $70
Evercore ISI Group analyst Greg Melich initiates coverage on BJ's Wholesale Club (NYSE:BJ) with a In-Line rating and announces Price Target of $70.
Raymond James Initiates Coverage On NBT Bancorp with Strong Buy Rating, Announces Price Target of $49
Raymond James analyst Steve Moss initiates coverage on NBT Bancorp (NASDAQ:NBTB) with a Strong Buy rating and announces Price Target of $49.
HC Wainwright & Co. Initiates Coverage On PepGen with Buy Rating, Announces Price Target of $26
HC Wainwright & Co. analyst Andrew Fein initiates coverage on PepGen (NASDAQ:PEPG) with a Buy rating and announces Price Target of $26.
Roth Capital Initiates Coverage On Phibro Animal Health with Buy Rating, Announces Price Target of $18
Roth Capital analyst Brian Wright initiates coverage on Phibro Animal Health (NASDAQ:PAHC) with a Buy rating and announces Price Target of $18.
Jefferies Initiates Coverage On ProKidney with Buy Rating, Announces Price Target of $15
Jefferies analyst Kelly Shi initiates coverage on ProKidney (NASDAQ:PROK) with a Buy rating and announces Price Target of $15.